Accelrys to Provide Integrated Software and IBM Hardware Solutions Through Avnet Hall-Mark's ESP Program.Business Editors/Health/Medical Writers/High-Tech Writers SAN DIEGO--(BUSINESS WIRE)--March 29, 2004 Accelrys First to Market, Deliver and Finance IBM (International Business Machines Corporation, Armonk, NY, www.ibm.com) The world's largest computer company. IBM's product lines include the S/390 mainframes (zSeries), AS/400 midrange business systems (iSeries), RS/6000 workstations and servers (pSeries), Intel-based servers (xSeries) Hardware Solutions to Life Sciences Organizations Through Avnet Hall-Mark's Enablement Services Partnership Program Accelrys Inc., a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of Pharmacopeia pharmacopeia /phar·ma·co·pe·ia/ (-ko-pe´ah) an authoritative treatise on drugs and their preparations. See also USP. pharmacopei´al United States Pharmacopeia see under U. , Inc. (Nasdaq:ACCL ACCL American Canadian Caribbean Line ACCL Acceleration ACCL American College of Construction Lawyers ACCL Accreditation Council for Clinical Lipidology (Allied Health Certification Program) ACCL Amway China Co Limited ) today announced that it will resell IBM hardware solutions through Avnet Hall-Mark's Enablement Services Partnership program (Avnet ESP (1) (Enhanced Service Provider) An organization that adds value to basic telephone service by offering such features as call-forwarding, call-detailing and protocol conversion. ). Avnet ESP will enable Accelrys to design, integrate, market, sell and finance IBM solutions -- on demand. This agreement builds on Accelrys' existing two-year strategic partnership with IBM and is in response to growing customer demand for IBM-based solutions in the Life Sciences marketplace. The program is initially targeted at US customers and is scheduled for roll out to European customers in the summer 2004 timeframe. "We are extremely pleased to be working with Avnet Hall-Mark and IBM to provide a simple, one-stop solution for customers who want to run Accelrys products on IBM hardware," said Mr. Mark Emkjer, president of Accelrys Inc. "By working through the Avnet ESP program, we will be able to streamline the fulfillment process for integrated, turnkey solutions to the Life Sciences market." "Accelrys is a leader in the Life Sciences software market and we look forward to working with them through the Avnet ESP Program," said Mr. Scott Abbott Scott Abbott is the co-inventor of Trivial Pursuit along with Chris Haney who was a photo editor for the Montreal Gazette. He is the current owner of the Brampton Battalion hockey team, of the Ontario Hockey League. , vice president of business development at Avnet Hall-Mark, IBM Division. "Accelrys will now be able to provide preloaded software installation and testing, and this will ensure that applications are up and running before they reach the customer site. We expect this rapid delivery and validation will lead to increased customer satisfaction." "We are very excited to be working with Accelrys and Avnet on end-to-end solutions to help accelerate drug discovery," said Dr. James Coffin, vice president, IBM Healthcare and Life Sciences. "Accelrys has been a consistent leader in drug discovery solutions and is well positioned to deliver the IBM hardware and services cost-effectively to our mutual customers." About Avnet Hall-Mark, IBM Division Headquartered in Tempe, Arizona, Avnet Hall-Mark is an industry-leading, value-added distributor of enterprise servers, storage, software and services, marketing exclusively to the reseller channel. Through operations in the United States, Mexico and Canada, Avnet Hall-Mark provides solutions from industry-leading manufacturers including BMC Software, EMC (1) (EMC Corporation, Hopkinton, MA, www.emc.com) The leading supplier of storage products for midrange computers and mainframes. Founded in 1979 by Richard J. Egan and Roger Marino, EMC has developed advanced storage and retrieval technologies for the world's largest companies. , HP, IBM, Microsoft, Network Appliance, Oracle, StorageTek and VERITAS -- driving growth for partners and manufacturers. Avnet Hall-Mark, IBM Division is part of the Avnet Technology Solutions operating group of Avnet Inc. (NYSE NYSE See: New York Stock Exchange :AVT AVT avian arginine vasotocin. See vasotocin. ), one of the world's largest technology marketing, distribution and services companies. Avnet's sales for fiscal 2003 (year ended June 27) were $9.05 billion. For more information about Avnet Hall-Mark, visit: www.hallmark.avnet.com. About Accelrys Inc. Accelrys is a leading provider of software for computation, simulation, and the management and mining of scientific data used by biologists, chemists, and materials scientists for product design, drug discovery, and development. Accelrys technology and services are designed to meet the needs of today's leading research organizations. The company is headquartered in San Diego, California “San Diego” redirects here. For other uses, see San Diego (disambiguation). San Diego is a coastal Southern California city located in the southwestern corner of the continental United States. As of 2006, the city has a population of 1,256,951. , USA. Accelrys is currently a subsidiary of Pharmacopeia, Inc. (Nasdaq:ACCL). When used anywhere in this document, the words expects, believes, anticipates, estimates, and similar expressions are intended to identify forward-looking statements. Forward-looking statements herein may include statements addressing future financial and operating results of Pharmacopeia. Pharmacopeia has based these forward-looking statements on its current expectations about future events. Such statements are subject to risks and uncertainties including, but not limited to, the successful implementation of Pharmacopeia's strategic plans, the acceptance of new products, the obsolescence ob·so·les·cent adj. 1. Being in the process of passing out of use or usefulness; becoming obsolete. 2. Biology Gradually disappearing; imperfectly or only slightly developed. of existing products, the resolution of existing and potential future patent issues, additional competition, changes in economic conditions, and other risks described in documents Pharmacopeia has filed with the Securities and Exchange Commission, including its most recent report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. and subsequent reports on Form 10-Q Form 10-Q See 10-Q. . All forward-looking statements in this document are qualified entirely by the cautionary statements included in this document and such filings. These risks and uncertainties could cause actual results to differ materially from results expressed or implied by forward-looking statements contained in this document. These forward-looking statements speak only as of the date of this document. Pharmacopeia disclaims any undertaking to publicly update or revise any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion